Comparing two methods for collecting bone marrow in hip surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves six patients with bone loss in the hip who will undergo minimally invasive repair. Participants will have bone marrow collected from both the surgical and non-surgical hips using two different systems: the standard Zimmer Biomet Biocue system and the novel Marrow Cellutions system™. The collected bone marrow will be processed to concentrate the cells and molecules, with the concentrated liquid from the surgical hip being delivered to promote healing. The goal is to evaluate the effectiveness of the new collection method compared to the traditional approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients aged 18 - 50
* patients undergoing hip arthroscopy for subchondral bone cysts and/or avascular necrosis

Exclusion Criteria:

* patients with a history of hematologic issues including anemia and sickle cell anemia
* patients with a history of leukemia, lymphoma, or other bone marrow related diseases
* patients with diabetes
* patients with a history of bone marrow aspirate

Where it's running

• Jameson Crane Sports Medicine Institute
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: William K Vasileff, MD — Ohio State University
• Study coordinator: Michael Keller
• Email: michael.keller@osumc.edu
• Phone: 614-293-2410

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How knee and hip joint replacements are doing over time

  This observational study follows adults who have knee or hip replacements to see how their outcomes look over time after the surgery.

  Recruiting University Hospital, Bonn · Bonn, North Rhine-Westphalia · NCT07799818

• VR After Hip Replacement: See if Virtual Reality Helps Pain and Comfort

  This study tests whether virtual reality can help adults recover after total hip replacement by reducing pain and anxiety and improving comfort.

  Recruiting Adiyaman University · Malatya · NCT07689461

• Comparing two nerve-block approaches for pain after anterior-approach hip replacement

  This trial tests whether adding a lateral femoral cutaneous nerve block or using surgical wound infiltration together with a PENG block gives better pain relief after anterior-approach total hip replacement.

  Recruiting Ospedale Edoardo Bassini · Cinisello Balsamo, Milano · NCT07284615

• PENG block versus combined lumbar and sacral erector spinae plane (ESP) blocks for pain after total hip replacement

  This trial will test whether the PENG nerve block or a combined lumbar-plus-sacral ESP block gives better pain relief and reduces opioid use in adults aged 65 and older having elective total hip replacement.

  Recruiting Phase 4 Poznan University of Medical Sciences · Poznan · NCT07180979

• PENG plus lateral femoral cutaneous nerve block versus lumbar and sacral erector spinae plane blocks for pediatric hip surgery

  This trial will test whether combining a PENG block with a lateral femoral cutaneous nerve block gives better pain relief and lowers opioid use than lumbar and sacral erector spinae plane blocks in children aged 2–16 having elective hip surgery.

  Recruiting Phase 4 Poznan University of Medical Sciences · Poznan · NCT07023094

• CoCrMo LOCK bipolar hip head safety and performance after hemiarthroplasty

  This study tests whether CoCrMo LOCK bipolar femoral heads perform safely and reliably after hip hemiarthroplasty in adults with displaced intracapsular hip fractures.

  Recruiting Limacorporate S.p.a · Celje · NCT06885359

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.